Bioorganic and Medicinal Chemistry Letters p. 2387 - 2392 (1996)
Update date:2022-09-26
Topics:
Wiley, Michael R.
Chirgadze, Nickolay Y.
Clawson, David K.
Craft, Trelia J.
Gifford-Moore, Donetta S.
Jones, Noel D.
Olkowski, Jennifer L.
Weir, Leonard C.
Smith, Gerald F.
The design, synthesis, and enzyme inhibitory profile of D-Phe-Pro-p-Amidinobenzylamine are presented. This compound has inhibitory activity equivalent to D-Phe-Pro-Arg-H, two orders of magnitude more potent than D-Phe-Pro-Agmatine. The results indicate that binding energy provided by the covalent bond of a transition-state analog can be replaced with noncovalent interactions.
View MoreShanghai Taibao Pharmaceutical Technology Co., Ltd(expird)
Contact:021-52217366
Address:shanghai
SICHUAN ZHONGBANG NEW MATERIAL CO., LTD
website:http://www.zhongbangst.com
Contact:86-830-2585019
Address:sichuan,china
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Shandong Yuanli Science and Technology Co., Ltd.
Contact:86-0536-6777557
Address:Zhuliu Industiral Park,Changle County
Jinan Jianfeng Chemical Co., Ltd
Contact:0086-531-88110457
Address:sales01(-a-t-)pharmachemm{dot}c+o+m
Doi:10.1246/bcsj.54.2065
(1981)Doi:10.1016/S0968-0896(98)00152-7
(1998)Doi:10.1016/s0020-1693(97)05682-x
(1997)Doi:10.1055/s-1995-4072
(1995)Doi:10.1016/0040-4020(68)88096-2
(1968)Doi:10.1021/ja9533003
(1996)
